The U.S. healthcare system faces a significant challenge with delayed diagnoses, especially for children suffering from neurological conditions such as epilepsy and developmental delays. This prolonged diagnostic journey, often termed the 'diagnostic odyssey,' can lead to emotional and financial strain on families. However, genomic sequencing, which analyzes thousands of genes to identify potential genetic causes of diseases, has emerged as a powerful tool. Recent studies indicate that when genomic sequencing is utilized early in the diagnostic process, healthcare costs can decrease dramatically. For instance, children with epilepsy experienced a 61% reduction in overall healthcare costs, translating to nearly $80,000 in savings per child annually. This shift from reactive to proactive care not only improves health outcomes but also alleviates financial pressure on Medicaid systems. The challenge lies not in the technology itself, which is widely available, but in its inconsistent application across different healthcare settings. To ensure equitable access to this life-saving technology, it is essential to integrate genomic sequencing into standard care practices across all medical facilities.